BIOVENTUS INC. - CLASS A COMMON STOCK

Bioventus to Present at the 43rd Annual J.P. Morgan Healthcare Conference

07 Jan 2025 07:00:01 By Nasdaq GlobeNewswire

Bioventus Completes Divestiture of its Advanced Rehabilitation Business to Accelmed Partners

02 Jan 2025 07:00:00 By Nasdaq GlobeNewswire

Bioventus Reports Third Quarter Financial Results

05 Nov 2024 06:30:00 By Nasdaq GlobeNewswire

Bioventus to Report Third Quarter of Fiscal Year 2024 Financial Results on November 5, 2024

29 Oct 2024 06:30:00 By Nasdaq GlobeNewswire

Bioventus Announces Divestiture of its Advanced Rehabilitation Business to Accelmed Partners

01 Oct 2024 08:00:01 By Nasdaq GlobeNewswire

Bioventus to Present at the Canaccord Genuity 44th Annual Global Growth Conference

07 Aug 2024 15:15:00 By Nasdaq GlobeNewswire

Bioventus Reports Second Quarter Financial Results

06 Aug 2024 06:30:00 By Nasdaq GlobeNewswire

Bioventus to Report Second Quarter of Fiscal Year 2024 Financial Results on August 6, 2024

30 Jul 2024 06:30:00 By Nasdaq GlobeNewswire

Bioventus Reports First Quarter Financial Results

07 May 2024 06:00:01 By Nasdaq GlobeNewswire

Bioventus to Report First Quarter of Fiscal Year 2024 Financial Results on May 7, 2024

29 Apr 2024 06:30:00 By Nasdaq GlobeNewswire

Bioventus Announces Fourth Quarter and Full Year 2023 Financial Results

12 Mar 2024 06:30:01 By Nasdaq GlobeNewswire

Bioventus to Report Fourth Quarter of Fiscal Year 2023 Financial Results on March 12, 2024

04 Mar 2024 07:00:00 By Nasdaq GlobeNewswire

Bioventus Enters into an Amendment with its Credit Agreement Lenders to Enhance Financial and Operational Flexibility

18 Jan 2024 15:15:00 By Nasdaq GlobeNewswire

Bioventus Announces Inducement Equity to President and Chief Executive Officer Robert Claypoole

12 Jan 2024 15:15:00 By Nasdaq GlobeNewswire

Bioventus Names Robert Claypoole as President and Chief Executive Officer

19 Dec 2023 15:30:00 By Nasdaq GlobeNewswire

Bioventus Agrees to Nationwide Contract with Aetna™ Medicare Advantage Plans for DUROLANE® for Knee Osteoarthritis

06 Dec 2023 07:00:00 By Nasdaq GlobeNewswire

Bioventus Reports Third Quarter Financial Results; Raises Full Year 2023 Financial Guidance

07 Nov 2023 06:00:01 By Nasdaq GlobeNewswire

Bioventus to Report Third Quarter of Fiscal Year 2023 Financial Results on November 7, 2023

31 Oct 2023 06:00:00 By Nasdaq GlobeNewswire

Bioventus to Present at the Cantor Global Healthcare Conference

19 Sep 2023 20:52:45 By Nasdaq GlobeNewswire

Bioventus to Present at the Morgan Stanley 21st Annual Global Healthcare Conference

06 Sep 2023 15:30:00 By Nasdaq GlobeNewswire